Urogen Pharma's total assets for Q3 2024 were $301.94M, an increase of 7.13% from the previous quarter. URGN total liabilities were $276.43M for the fiscal quarter, a 9.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.